Back to mobile site

Form SCHEDULE 13G KALA BIO, Inc. Filed by: Labkowski Nachum

October 19, 2026 9:09 AM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The amount set forth in rows (5), (7) and (9) include (i) 57,21 common shares ("Common Shares") of Kala Bio, Inc. (the "Issuer") directly held by the reporting person, and (ii) 909,720 Common Shares held by Halevi Enterprises LLC, a Delaware limited liability company, which the reporting person has sole voting and sole dispositive power over. The percentage set forth in row (11) is calculated based on 19,339,786 Common Shares of the Issuer issued and outstanding of as August 14, 2026 as reported in the Quarterly Report on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on August 19, 2026.


SCHEDULE 13G



 
Labkowski Nachum
 
Signature:Nachum Labkowski
Name/Title:Nachum Labkowski
Date:10/19/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G